"Breaking Down the Science: Illustrating the updates on the Cell-free DNA-derived methylome for Coronary artery disease"
- Xulfikar Mehdi
- Apr 7, 2024
- 1 min read
Recently, our research team at the Central Molecular Lab, GIPMER published a review article entitled, "An update on the cell-free DNA-derived methylome as a non-invasive biomarker for coronary artery disease". The highlights of this article were;
Cardiac cell necrosis by atherosclerotic plaque rupture triggers myocardial infarction.
Cell-free DNA released from the necrotized cells represents the tissue specificity.
cfDNA is explored to comprehend the epigenomic landscape and CAD pathophysiology.
The differential methylation pattern in CAD patients can be a potential biomarker(s) to detect CAD.
I was very fortunate to contribute in the drafting and visualization part of this manuscript. Here are the illustrations that I made using Adobe Illustrator that got published in this article;

Graphical abstract: Highlights the risk factors associated with CAD, methods to study and applications of the data derived from exploring the methylome from cfDNA of CAD patients.

Figure 1: Schematic representation of the homocysteine pathway in its normal homeostasis and the epigenetic changes leading to atherosclerosis.

Figure 2: Technical approaches to study methylation with their advantages, and limitations.
Reference: https://doi.org/10.1016/j.biocel.2024.106555
.png)

Comments